Literature DB >> 18687773

Expanding the mind: insulin-like growth factor I and brain development.

A Joseph D'Ercole1, Ping Ye.   

Abstract

Signaling through the type 1 IGF receptor (IGF1R) after interaction with IGF-I is crucial to the normal brain development. Manipulations of the mouse genome leading to changes in the expression of IGF-I or IGF1R significantly alters brain growth, such that IGF-I overexpression leads to brain overgrowth, whereas null mutations in either IGF-I or the IGF1R result in brain growth retardation. IGF-I signaling stimulates the proliferation, survival, and differentiation of each of the major neural lineages, neurons, oligodendrocytes, and astrocytes, as well as possibly influencing neural stem cells. During embryonic life, IGF-I stimulates neuron progenitor proliferation, whereas later it promotes neuron survival, neuritic outgrowth, and synaptogenesis. IGF-I also stimulates oligodendrocyte progenitor proliferation although inhibiting apoptosis in oligodendrocyte lineage cells and stimulating myelin production. These pleiotropic IGF-I activities indicate that other factors provide instructive signals for specific cellular events and that IGF-I acts to facilitate them. Studies of the few humans with IGF-I and/or IGF1R gene mutations indicate that IGF-I serves a similar role in man.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687773      PMCID: PMC2613055          DOI: 10.1210/en.2008-0920

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

1.  Neural stem cells.

Authors:  Nigel L Kennea; Huseyin Mehmet
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

2.  Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells.

Authors:  G J Brooker; M Kalloniatis; V C Russo; M Murphy; G A Werther; P F Bartlett
Journal:  J Neurosci Res       Date:  2000-02-01       Impact factor: 4.164

3.  Sensorineural hearing loss in insulin-like growth factor I-null mice: a new model of human deafness.

Authors:  R Cediel; R Riquelme; J Contreras; A Díaz; I Varela-Nieto
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

4.  Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2.

Authors:  Y Arsenijevic; S Weiss; B Schneider; P Aebischer
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

5.  Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex.

Authors:  M M Niblock; J K Brunso-Bechtold; D R Riddle
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 6.  The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders.

Authors:  W Zumkeller
Journal:  Eur J Paediatr Neurol       Date:  1997       Impact factor: 3.140

7.  Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development.

Authors:  J R O'Kusky; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 8.  Insulin-like growth factor-I and neurogenesis in the adult mammalian brain.

Authors:  Michelle F Anderson; Maria A I Aberg; Michael Nilsson; Peter S Eriksson
Journal:  Brain Res Dev Brain Res       Date:  2002-03-31

Review 9.  Insights from insulin-like growth factor binding protein transgenic mice.

Authors:  Josef V Silha; Liam J Murphy
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

10.  Myelination is altered in insulin-like growth factor-I null mutant mice.

Authors:  Ping Ye; Liqin Li; R Gregg Richards; Richard P DiAugustine; A Joseph D'Ercole
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

View more
  89 in total

1.  Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus.

Authors:  Sarah M Dickerson; Stephanie L Cunningham; Andrea C Gore
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-26       Impact factor: 4.219

Review 2.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 3.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

4.  Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus.

Authors:  Phu V Tran; Stephanie J B Fretham; Jane Wobken; Bradley S Miller; Michael K Georgieff
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-16       Impact factor: 4.310

Review 5.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

6.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

Review 7.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Gender differences and lateralization in the distribution pattern of insulin-like growth factor-1 receptor in developing rat hippocampus: an immunohistochemical study.

Authors:  Javad Hami; Hamed Kheradmand; Hossein Haghir
Journal:  Cell Mol Neurobiol       Date:  2013-11-28       Impact factor: 5.046

9.  The regulatory mechanism of neurogenesis by IGF-1 in adult mice.

Authors:  Honghua Yuan; Renjin Chen; Lianlian Wu; Quangang Chen; Ankang Hu; Tengye Zhang; Zhenzhen Wang; Xiaorong Zhu
Journal:  Mol Neurobiol       Date:  2014-04-29       Impact factor: 5.590

Review 10.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.